78 related articles for article (PubMed ID: 8223982)
1. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
Kratzsch J; Blum WF; Schenker E; Keller E; Jahreis G; Haustein B; Ventz M; Rotzsch W
Exp Clin Endocrinol; 1993; 101(3):144-9. PubMed ID: 8223982
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
[TBL] [Abstract][Full Text] [Related]
4. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
5. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
Kratzsch J; Blum WF; Schenker E; Keller E
Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
[TBL] [Abstract][Full Text] [Related]
6. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
[TBL] [Abstract][Full Text] [Related]
7. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
[TBL] [Abstract][Full Text] [Related]
9. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
Thissen JP; Ketelslegers JM; Maiter D
Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion.
Rasat R; Livesey JL; Espiner EA; Abbott GD; Donald RA
N Z Med J; 1996 May; 109(1021):156-9. PubMed ID: 8657365
[TBL] [Abstract][Full Text] [Related]
11. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
12. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
[TBL] [Abstract][Full Text] [Related]
14. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
Massart C; Poirier JY
Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
17. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.
Frystyk J; Dinesen B; Orskov H
Growth Regul; 1995 Dec; 5(4):169-76. PubMed ID: 8745141
[TBL] [Abstract][Full Text] [Related]
18. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
Reeves I; Abribat T; Laramee P; Jasmin G; Brazeau P
Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
[TBL] [Abstract][Full Text] [Related]
19. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I.
Miyakawa M; Hizuka N; Takano K; Tanaka I; Horikawa R; Honda N; Shizume K
Endocrinol Jpn; 1986 Dec; 33(6):795-801. PubMed ID: 3582265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]